Our DSP analysis further supports this idea by revealing that AR protein expression negatively correlates with CD45 abundance in ovarian and SARC cancers, and with CD4 in SARC, reinforcing AR’s role in promoting an immunosuppressive TME. Here, CD4 is linked to cancer.